| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  PhotonPath Intelligent Photonic Integrated Circuits PhotonPath is a leader in the field of Integrated Photonics. Born in 2019 as a Spinoff of Politecnico di Milano, we offer innovative solutions for sensing and communication. Our cutting-edge Photonic Integrated Circuits (PICs) are used in a wide range of applications, including optical sensing for the automotive industry and high-capacity, low-loss programmable equipment for telecommunications networks. Our proprietary platform and technology stack enable us to efficiently manufacture and test our products, ensuring their reliability and competitiveness in the market. We offer fully functional Integrated Photonics-based solutions that are easy to use thanks to our comprehensive … | 3 | 1 | 2 | 11 |
 | Leo Cancer Care THE MORE HUMAN WAY TO TREAT CANCER LEO CANCER CARE WAS FOUNDED WITH TWO POWERFUL GOALS 1. Improve the quality of Radiation Therapy delivery through upright positioning 2. Improve access to Radiation Therapy through the removal of gantries Leo Cancer Care was founded with more than 100 years of Radiation Therapy experience by a team dedicated to challenging the norms in everything we do. Patient’s lives influence us to find a better way, a better way to improve patient care and how a patient experiences it. A better way to increase the accessibility of cancer treatments for more patients in … Type: | 0 | 0 | 0 | 101 |
 |  Baby Food Factory We are Baby Food Factory and our mission is to provide the right and healthy nutrition choices for all generations. By applying state-of-the-art technology and equipment, along with latest industry standards to process raw materials of highest quality, coming only from certified suppliers, we take health and safety measures seriously - all our production lines are equipped with “clean-room panels", a high-end precaution process used only in medical or pharmaceutical industries. We’re constantly developing new products and improving our packaging towards more functional and user-friendly solutions. In our portfolio, we have Nutrino and Nutrino Lab brands. NUTRINO is a high-quality, … Type: | 0 | 0 | 0 | 88 |
 | Rivia Integrated Clinical Trial Intelligence Rivia specializes in AI-driven analytics and data infrastructure for more successful biopharma clinical trials. Biopharmas are the origin of most new therapies, yet often face inefficiencies and failures in clinical trials due to fragmented data and outdated tools. Our technology offers a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. Our vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully. https://rivia.ch/ Type: | 2 | 0 | 2 | 8 |
 | Tiziana Life Sciences Tiziana Life Sciences LTD is a NASDAQ listed (NASDAQ:TLSA) clinical stage biotechnology company Tiziana Life Sciences LTD is a biotechnology company focused on transformational technology enabling alternative routes for immunotherapy . https://www.tlsainfo.com/ | 1 | 0 | 1 | 7 |
 | Moleculent Discover Function Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in life science. #cellcellcommunication | 0 | 0 | 0 | 49 |
 | Black Semiconductor Converging Photonics and Electronics We are Black Semiconductor, a fast-growing deep-tech company based in Aachen, Germany. Our goal is to manufacture and commercialise extremely powerful microchips with integrated electronic photonic circuitry, leveraging the potential of graphene. Type: | 4 | 0 | 3 | 39 |
 | Qblox We enable the quantum revolution with our proprietary control stack technology. At Qblox we operate at the frontier of the quantum revolution. With a dedicated team of scientists, engineers and developers we are pushing quantum technology to support scientists worldwide with our scalable and low-latency qubit control equipment. We are the sole providers of quantum control stacks that can be easily integrated with our customers’ quantum computers. The stacks combine unlevelled noise performance, low-latency arbitrary control flows and can be scaled up to 100s of qubits. Our company is based in the Netherland and a spinoff of QuTech, which enables … | 0 | 0 | 0 | 101 |
 | Bright Peak Therapeutics Better Biologics Through Chemistry Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases. Through a variety of proprietary technology platforms, Bright Peak is uniquely abled to conjugate its cytokines as payloads to antibodies, creating bespoke, novel and proprietary “Bright Peak Immunocytokines”, and to other cytokines as “duokines”. The Bright Peak Immunocytokines allow tissue- and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy. One of the many advantages of our approach is its "off-the-shelf" feature. Using a pioneering site-specific ADC-like chemical … Type: | 1 | 0 | 0 | 54 |
 | CUREosity GmbH virtual therapy - real success CUREosity is an award-winning medtech company based in Düsseldorf, Germany, focusing on Virtual Reality therapy through gamification. With our vision to revolutionize traditional rehabilitation, we develop VR-based therapy applications for clinics and practices. The advantages of the one-of-a-kind therapy system CUREO are (among others): Evidence-based therapeutic success, sustainable relief of personnel, increased patient motivation, a wide range of applications and an easy and intuitive usability. In a collaborative approach with scientists, doctors and therapists from major clinics and partner practices, our developers and in-house medical experts are constantly striving to further improve therapy by making … Type: | 0 | 0 | 0 | 39 |
 | Augustine Therapeutics Innovative Therapies for Neuromuscular and Neurodegenerative Disorders Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies and neurodegenerative disorders. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by Asabys Partners, Eli Lilly and Company, V-Bio Ventures, PMV, AdBio Partners, VIB, Gemma Frisius Fund and CMT Research Foundation. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge … Type: | 0 | 0 | 0 | 14 |
 | Medannex Ltd Award-winning Scottish biopharmaceutical company, advancing the treatment of cancers and autoimmune diseases. Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology. Antibody development, Innovation, Biotechnology, T cell modulation, Skills development, Autoimmune diseases, Inflammation, Lupus, SLE, Collaboration, … Type: | 1 | 0 | 1 | 11 |
 |  BrainHealthClinic Specialist Neuropsychiatry Clinic for Adult ADHD, Autism, FND, Dementia, Psychosis, Bipolar, Depression, Anxiety Brain Health Clinic is a specialist neuropsychiatry clinic for adults . We have specialist expertise in diagnosis and treatment of most brain related conditions including Adult ADHD, Autism, Sleep Disorders, Psychosis, All Dementias including Alzheimer’s disease, Biological Depression, Anxiety Disorders, OCD, Functional Neurological Disorder (FND) and Neuropsychiatry of Neurological conditions such as Parkinson’s Disease, Epilepsy and Multiple Sclerosis Type: | 0 | 0 | 0 | 2 |
 | Herantis Pharma Plc. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’ lead product HER-096, is an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein. It combines the compelling mechanism of action of CDNF with the convenience of subcutaneous administration. A Phase 1a clinical trial has demonstrated a good safety and tolerability profile, and efficient blood-brain barrier penetration of subcutaneously administered HER-096 in humans. The shares of Herantis are listed on the Nasdaq First … Type: | 1 | 0 | 1 | 21 |
 | StarTric Transcatether Tricuspid Valve Repair StarTric is developing an innovative structural heart technology to treat the regurgitation of the tricuspid valve. StarTric is the first and only minimally invasive repair device, conceived as a transcatheter replica of the highly effective open surgery technique, the edge-to-edge Clover repair. History StarTric founders include Prof. Ottavio Alfieri, who contributed to cardiac surgery with his “Alfieri-stich” or “edge-to-edge” repair of the mitral valve, and Prof. Michele De Bonis: together they pioneered the Clover technique for the repair of the tricuspid valve. Building on this legacy, StarTric transcatheter device is designed to replicate the results of … Type: | 0 | 0 | 0 | 2 |
 | Smartfarma [Automatic translation follows] Research and innovation to grow together Smartfarma was created to help parents and doctors raise healthy and strong children. We constantly invest in research to offer better products to provide the correct vitamin intake and to strengthen the immune system of newborns, children and new mothers. We believe in innovation with high added value, which is why we are pioneers in the use of postbiotics in the neonatal field, excipients of extraordinary effectiveness in strengthening the immune defenses. Scientific research is our distinctive element. We are the first and only company in Italy to have a line … | 0 | 0 | 0 | 16 |
 | OmicsChart Multi-Omics for Translational Cancer Research OmicsChart is a computational cancer biology startup revolutionising translational cancer research with our proprietary multi-omics cancer biomarker discovery platform. Our platform enables rapid access and analysis of harmonised biomarker data for 35 cancer indications through domain-specific AI and machine learning, reducing data acquisition and analysis time by 150 times compared to current practices. Our solution allows translational cancer scientists to quickly test hypotheses and extract insights from a harmonised mix of public and proprietary biomarker data. Built on federated data integration and domain-driven ML/AI, our platform features biologist-friendly scientific visualisations. We provide comprehensive insights on … Type: | 7 | 0 | 1 | 6 |
 | Saventic Health AI-driven diagnosis of rare diseases We are a med-tech company that creates artificial intelligence algorithms to support doctors in diagnosing rare (hidden) diseases early based on patients' medical records i.e. laboratory test results, radiology and other descriptive medical data. artificial intelligence, AI, healthcare diagnostic, healthcare, precision medicine, rare diseases, oncology, hemathology, clinical decision support tools, clinical decision support system, Blood cancers, Rare blood & marrow diseases, Metabolic storage diseases, Immune system disorders, and Skin & tissue diseases Type: | 0 | 0 | 0 | 41 |
 | e-therapeutics PLC Computing the future of medicine A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics Type: | 0 | 0 | 0 | 51 |
 | Sphera Encapsulation S.r.l. Microtechnologies, macro results. The demand for research and development of new delivery systems and formulation of bioactive compounds or molecules with specific characteristics is increasing worldwide. This tendency is supposed to grow in the next decade as a consequence of the creation of new reliable formulations, the higher competition between industries and the ambition for designing new concepts on a lower price. To satisfy this demand, many of the already existing formulation should be constantly upgraded as consumers have dynamic requirements. Our company Sphera S.r.l. is born out of the desire to respond to the high demands of the encapsulation … | 0 | 0 | 0 | 8 |
 | PharmNovo Innovation in pain relief PharmNovo AB is a clinical-stage pharmaceutical company focused on developing safe and effective drugs for neuropathic pain. In this area, there is currently a lack of sufficient treatments. The company’s drug candidate, PN6047, effectively reduces neuropathic pain in animal models and the findings from the Phase I trial show that PN6047 is safe and well-tolerated at the doses tested, with no serious adverse events reported. Furthermore, PN6047 exhibited none of the adverse events typically associated with the conventional opioids like oxycodone and morphine, such as respiratory depression, constipation, itching, or signs of abuse potential. This validates … Type: | 0 | 0 | 0 | 10 |
 | NematX AG 10x stronger than PEEK - >250°C heat resistance - inert material properties NematX AG is a Swiss startup specialized in additive manufacturing. Founded as a spin-off company from the Swiss Federal Institute of Technology (ETH Zurich) in 2020, NematX aims to introduce the next generation in high-performance polymer 3D printing. Their "Nematic 3D Printing" technology allows for the production of high performance end-use parts which clearly outperform current benchmarks in polymer 3D printing. Target industries of NematX include Aerospace & Space, Medical, Electronics and all industrial applications where parts are exposed to harsh environmental conditions. 3D Printing, Additive Manufacturing, High-Performance … Type: | 0 | 0 | 0 | 9 |
 | CellCentric Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers. Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise … Type: | 2 | 1 | 1 | 22 |
 | 4D Biomaterials 4Degra® 3D printing biomaterials - helping people heal. Regenerative, resorbable and customisable. The market for polymeric biomaterials is growing quickly, but despite this growth, it is widely recognised in the industry that the ‘holy grail’ solution has not yet been developed. The ideal biomaterial for use in regenerative medicine must: be biocompatible; promote tissue regeneration; have non-toxic biodegradation, have mechanical properties suited to the host tissue and good handling properties in a clinical environment. Our people have developed a patented range of novel polymeric 3-D printing resin-inks that promise, uniquely, to meet all of the above requirements and offer important … Type: | 0 | 0 | 0 | 9 |
 | ARGONAUTE RNA LIMITED Argonaute RNA Ltd. is developing safe and reliable methods of temporarily silencing target genes in different tissue cells. Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. We show how our proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression. We use a novel method of stabilising the siRNA and thereby avoid a range of issues which have … Type: | 0 | 0 | 0 | 10 |
 | Integra Therapeutics Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases At Integra Therapeutics we have combined the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases. Harnessing what nature has evolved to introduce large pieces of DNA into the genome, together with the precision of sequence specific DNA binding proteins, has allowed for unprecedented efficiency in programmable gene delivery. Type: | 2 | 1 | 1 | 20 |
 | Draupnir Bio Bringing innovative therapies to patients Draupnir Bio is a Danish biotechnology company driven by a deep commitment to scientific excellence and the desire to bring innovative therapies to patients in need. By harnessing the natural machinery of the lysosome, we are developing oral, small molecule degraders of extracellular pathogenic proteins – the next frontier of targeted protein degradation (TPD), a rapidly emerging field that exploits a cell’s own destruction machinery to tackle disease-causing proteins that have historically been highly challenging to target with conventional therapies. First-generation TPD approaches are exclusively limited to intracellular targets, leaving extracellular and membrane-bound proteins – … Type: | 0 | 0 | 0 | 15 |
 | Pan Cancer T Pan Cancer T is a biotechnology company developing T cell receptor (TCR) T-cell therapy for solid tumors. Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges. Type: | 1 | 1 | 0 | 9 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: | 2 | 1 | 2 | 15 |
 | Asceneuron SA Targeting the root cause of neurodegeneration Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & … Type: | 3 | 2 | 2 | 20 |
 | Akadeum Life Sciences, Inc. Better Isolations. Healthier Cells. Akadeum Life Sciences® has developed a next generation platform that solves long-standing problems across cell therapy and other research, diagnostic and therapeutic markets. The proprietary buoyant microbubble technology platform addresses the need for high cell quality, scalability, time and workflow that current magnetic particle-based products commonly used in cell therapy manufacturing and research can’t address. The Company has several GMP grade and Clinical Ready kits to enable each stage of cell therapy manufacturers pipeline. Harnessing the microbubble capability, the AlerionTM Microbubble Cell Separation System enables cell isolation from tens of billions of cells in apheresis material … Type: | 1 | 1 | 0 | 32 |
 | Genomenon, Inc Genomic intelligence for clinical diagnostics and precision medicine development Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data, and services. Genomenon offers advanced genomic software solutions designed to streamline and enhance genetic research and clinical decision-making. Our flagship product, the Mastermind® Genomic Intelligence Platform, provides comprehensive genomic data integration and analysis, offering researchers and clinicians … Type: | 1 | 1 | 0 | 144 |
 | Delphinus Medical Technologies, Inc. Delivering medical innovations to transform early detection of breast cancer and save women’s lives all over the world. Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Called SoftVueTM, and featuring proprietary TriADTM (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals … Type: | 1 | 1 | 0 | 67 |
 | one • fıve AI powered packaging for modern products Welcome to one.five - a frontrunner in AI-powered modern packaging solutions. At one.five, we redefine the packaging landscape, leveraging cutting-edge AI technology to deliver unparalleled performance, affordability, and sustainability. As industry pioneers, we recognise that mastering modern packaging necessitates embracing AI at its core. Our expertise empowers decision-makers to discover the ultimate packaging solution, driving efficiency, cost-effectiveness, and environmental stewardship. Join us in shaping the future of packaging with innovation, intelligence, and integrity. #onefive #AI #PackagingInnovation | 2 | 2 | 0 | 52 |
 | SnoFox Sciences A technology company providing sophisticated solutions for future-ready companies SnoFox Sciences provides analytics focused on increasing efficiency and decreasing energy usage for the cold industrial space with no additional hardware required. Here at SnoFox, one of our core pillars is a commitment to marrying scientific pursuit and commercial value. It is with that commitment in mind that we set out to provide the first and only thermodynamically-informed data analytics platform for cold chain monitoring and preventative maintenance. At the intersection of thermodynamics, data science, and mechanical engineering, SnoFox Sciences plans to revolutionize our collective understanding of the global cold chain. Type: | 3 | 2 | 1 | 15 |
 | SwaLife Biotech At Swalife Biotech, we are at the forefront of developing next-generation therapies for cancer and chronic diseases. Our research is rooted in the discovery of five novel bioactive alkaloids from plants, aimed at synthesizing compounds that target key mechanisms in skin and breast cancer. We leverage cutting-edge technologies such as network pharmacology and AI to enhance our understanding and development of drug therapies. Our alkaloids have shown promising results in inhibiting the DNA Damage Response (DDR) pathway, crucial in preventing drug resistance and cancer cell survival. Our innovative approach not only targets cancer but also extends to managing chronic diseases, … Type: | 0 | 0 | 0 | 3 |
 | Mello Enabling probiotics and bioactives for healthier, more sustainable solutions of tomorrow Mello aims to enable the powerful effect of probiotics and bioactives so that they can be used to enhance your health and wellbeing. We're pioneering a groundbreaking encapsulation ?technology securing unparalleled effectiveness in the human body. Our unique delivery solutions will solve the longstanding challenge of delivering bioactives, to a specific target location in the body, effectively. Probiotic encapsulation, micro-encapsulation, and Encapsulation technology Type: | 1 | 1 | 0 | 10 |
 | Yepic AI We use video to transform human-AI interaction. We use video to transform human-AI interaction. Our technology enables you to create videos of talking, multilingual avatars, made from a single photo, and to interact in real-time with AI Video Agents. artificial intelligence, computer vision, adobe, dynamic creative, AI, and Deep tech Type: | 13 | 1 | 6 | 14 |
 | The Rehab Physio World-leading technology and expertise to help patients with neurological conditions to optimise their recovery.. The Rehab Physio provides specialist neurological physiotherapy using advanced technology and techniques to help patients with catastrophic injuries or complex neurological conditions to achieve the best possible outcomes. Founded in 2011 by Christopher and Jennifer Wynne, The Rehab Physio was created to deliver the best, affordable care in this under-serviced sector. Specialist rehabilitation services have traditionally been difficult to access so their dream was to open a clinic where patients would have access to both experienced physiotherapists, trained in advance techniques, but also the latest technology … Type: | 1 | 0 | 1 | 15 |
 | JASA The leading source of theoretical and experimental research results in the broad interdisciplinary subject of sound. | 4 | 3 | 7 | N/A |
 | Inscripta, Inc. The Digital Genome Engineering Company Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc. Digital Genome Engineering, Gene Editing, Synthetic Biology, Genome Editing, CRISPR, … Type: | 3 | 1 | 2 | 74 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s leading predictive simulation of patient biology. We will empower the biopharma industry by informing the right experiments that identify and validate disease driving hidden effects. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals Type: | 4 | 0 | 4 | 102 |
 | Thunder Power (TPEV) Manufacturer of premium electric vehicles. With R&D headquarters in Milan, production in Europe & Asia, Thunder Power combines the very best of European technology, Italian styling and race-derived dynamics. The automotive world is entering an age of digital disruption. Thunder Power believes that it is not a question of if but when the EV goes mainstream. Thunder Power's vision is to establish a compu-motive business for the future. Automotive, Research & Development, Electric Vehicle, and Manufacturing Type: | 0 | 0 | 0 | 13 |
 | Insilico Medicine #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, … Type: | 18 | 1 | 15 | 282 |
 | Neva Aerospace Developing heavy drones for industrial applications: the next generation of Unmanned Air Vehicles (UAVs) and Air Utility Vehicles (AUVs). Neva combines VTOL & linear flight capabilities with remarkable stability and the capacity to carry loads ranging from freight to robotic arms weighing from 2kg to 2 tonnes. We have recently released the world's first electric turbofans optimised for static thrust and VTOL/STOL. This is the technology that unlocks huge potential for the development of commercial UAVs, both at Neva and in the OEM market. Wherever remote or dangerous access and 24/7 operations are involved, Neva Aerospace’s UAV/AUV technology is the … Type: | 0 | 0 | 0 | 2 |
 | Caura Everything car. All in one place. Caura is making car admin easy. Welcome to an entirely new way to manage everything car, all in one place. Tolls, city charges, insurance, tax and MOT on a single platform, with much more to come. We raised $4.2m in 2021 from investors such as TwinFocus and InMotion Ventures (the investment arm of Jaguar Land Rover), and we’re growing quickly. Two-tap payments for London’s Congestion Charge, ULEZ, Dartford Crossing, Clean Air Zones, airport drop-off charges, road tax, tolls and more. No more fines, and all your receipts stored in once place. We partner with … Type: | 2 | 2 | 0 | 35 |
 | Machine Medicine Motor assessment made simple and scalable through video We are a team based in London, that develops a platform to help assess people with Parkinson’s disease better. Motor assessment in Parkinson’s disease is plagued by issues of subjectivity and reproducibility – not to mention systematic biases such as rater drift. To counter this, we are developing a platform, called Kelvin, that can be used from any device (e.g. smartphones or tablets). Named after the famous physicist so beloved of precise measurement, the platform allows researchers to record, score, store and analyse video of Parkinson’s patients during motor assessment. Once captured … Type: | 1 | 1 | 0 | 21 |
 | Unmind Wellbeing that works. Creating a world where mental health is universally understood, nurtured, and celebrated. Unmind is the workplace wellbeing platform on a mission to create mentally healthy workplaces, where everyone can flourish. We partner with some of the world’s biggest brands (like Major League Baseball, Nationwide, Disney, Standard Chartered, Mediacom and British Airways) to give over 2.5 million people the right support at the right time. Unlike 95% of wellbeing solutions, we’re built on science. We take a whole organisation approach, giving people at all levels the tools they need to thrive. Psychology, Workplace Wellness, Health & Wellbeing, Mental … Type: | 17 | 2 | 14 | 217 |
 | Puraffinity We Protect Environmental & Human Health by Engineering Targeted Materials to Capture Chemicals Puraffinity is a spinout company from Imperial College London that specialises in designing and manufacturing novel advanced materials for environmental benefit, such as removing harmful pollutants from water and wastewater. Focusing initially on PFAS removal, Puraffinity has developed an innovative adsorbent media allowing an easily deployable solution for addressing PFAS compliance. In addition, the solution is highly cost effective, providing an attractive Return On Investment for customers, and reduced life-cycle costs. Founded in 2015, Puraffinity is backed by leading sustainability investors Kindred Capital, Heritage Group Ventures and … Type: | 8 | 0 | 4 | 34 |
 | The Medicine Maker The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form Type: | 17 | 2 | 15 | 1 |
 | Aridhia – Digital Research Environment – DRE A world-class Digital Research Environment that delivers for Life Science, Academia and Research Delivering the Aridhia Digital Research Environment (DRE), the trusted, secure, self-service, cloud-enabled digital research environment for biomedical, precision medicine and healthcare researchers Aridhia DRE delivers secure, auditable workspaces for research teams to engage personally, collaboratively and productively around data from multiple systems and sources in order to address complex data challenges. Commit to Rapid, Efficient and Collaborative Innovation Driven by Data. Aridhia DRE makes it easy to assemble your people, tools and data assets in secure, open source analytic workspaces to accelerate data-driven projects like never before. … Type: | 15 | 0 | 9 | 58 |
 | Immunocore Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechology, Pharmaceutical, ImmunoOncology, t-cells, infectious disease, oncology, ImmTacs, immune system, hiring, biologics, autoimmune, jobs, scientists, regulatory affairs, and CMC Type: | 5 | 1 | 1 | 527 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 4 | 2 | 3 | 56 |
 | CHAIN Biotechnology Ltd Superior and effective microbiome therapeutics CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research Centre at the University of Nottingham. CHAIN has developed a proprietary microbial platform for drug delivery. The platform builds on core engineering skills and involves the development and use of engineered Clostridia to deliver specific … Type: | 0 | 0 | 0 | 11 |
 | Togetherall An anonymous, accessible and safe place to support each other We’ve spent more than 16 years building a safe online community for members to take control, get support, and feel better. People come to Togetherall for support with a wide range of mental health and wellbeing issues – from anxiety, depression, loneliness, isolation, and stress, to relationship problems, and other life challenges. The safety of our members and clinical rigour is at the core of what we do, and we have a network of licensed mental health practitioners providing 24/7/365 support around the world. ✔ Peer-to-peer community– giving and receiving … Type: | 0 | 0 | 0 | 66 |
 | Newcells Biotech Ltd In vitro models to accelerate clinical translation We’re here to accelerate your therapy’s journey through the complexities of drug discovery and development. Putting innovation at the forefront of our capabilities, industry-leading experts help you confidently and proactively answer critical questions around the safety and efficacy of your product with our gold-standard in vitro models. By harnessing the power of predictive data, we navigate this crucial step efficiently and cost-effectively to maximise the potential of your therapy achieving clinical and market success. By combining our unique expertise with cutting-edge technologies, we’ve created predictive in vitro models that offer targeted solutions to … Type: | 0 | 0 | 0 | 47 |
 | SageTech Medical Leading Sustainable Anaesthesia SageTech Medical has developed a safe, sustainable and easy to use circular economy solution that captures, recovers and recycles environmentally harmful waste volatile anaesthetic agents for future reuse. The innovative solution integrates simply, seamlessly and universally into existing anaesthetic equipment, with no need for change in clinical practice. Type: | 3 | 1 | 1 | 17 |
 | Genomics plc Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for all the common diseases and cancers, well ahead of … Type: | 11 | 4 | 11 | 141 |
![LCC [Liverpool ChiroChem]](/media/logo/101424.jpeg){kind=logo} | LCC [Liverpool ChiroChem] Bring new compounds to market faster, better, and easier. Liverpool ChiroChem is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs. LCC was established in Liverpool, United Kingdom, in June 2014. The company has developed a suite of synthetic methodologies that have been used to produce thousands of novel, multifunctional 3D-rich, chiral fragments/scaffolds/BB’s to support NCE discovery & development (e.g. Fragments, DEL, VLS, Bifunctional Linkers). LCC is continuously expanding its 3D chemical space and has recently launched a 1.4Bn member Ultra-Large Virtual Library designed based on its proprietary scaffolds and supported by … Type: | 2 | 0 | 0 | 30 |
 | DIAG2TEC Preclinical CRO in Hematological Cancers Diag2Tec is an expert preclinical CRO devoted to hematological cancers, especially Multiple Myeloma (MM). We focused on in vitro Drug Testing in Human Hematological Cancer derived Cell Lines and Primary Cells from patients with various Hematologic Malignancies (Multiple Myeloma, Diffuse Large B Cells Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Mantle cell Lymphoma, Chronic Lymphoid Leukemia...). With our 2 platforms : Drug Testing Services and ChimioFx, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and phamaceutical companies to focus their drug development on … Type: | 1 | 1 | 0 | 8 |
 | NeoVirTech Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. The company has been highlighted in the Top10 drug discovery companies, Europe, 2019 by the PharmaTechOutlook Magazine. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging. At NeoVirTech, we believe everyone can have access to state-of-the-art virology techniques. We are focusing our activities on antiviral discovery, study of oncolytic and … Type: | 7 | 1 | 6 | 6 |
 | ODONTELLA [Automatic translation follows] The company has filed patents relating to the use of Odontella, the world's first marine microalgae authorized for human consumption. These patents concern the formulation, based on the marine microalgae Odontella, of a wide range of new agri-food products, healthy for the whole family. (Beverages, ready meals, etc.) The company is working on a new value chain, based on Odontella, by developing the first marine plant-based salmon that can directly replace the consumption of farmed salmon, in terms of taste, appearance, texture, nutritional quality and also price. This patented product developed in partnership with specialized laboratories is … Type: | 1 | 1 | 0 | 2 |
 | Kaer Labs In vivo small and large animal near infrared fluorescence imaging Kaer Labs develops and sells innovative in vivo fluorescence imaging solutions for researchers. Our systems are used by academic and private laboratories working on medical or pharmaceutical research In vivo near infrared fluorescence, Molecular Imaging, and Small and large animal open fluorescence Type: | 2 | 2 | 0 | 7 |
 | AVIACOMP About AVIACOMP ... AVIACOMP, as part of SOGECLAIR Group, is a leading company in Composite Thermoplastics and major supplier for fuel tanks access covers for both major aircraft programs. Being both acting as research & technology actor and reliable industrial manufacturer within aeronautic market, AVIACOMP provides its customers with long term solution and high complexity and quality products on most innovative programs. Firmly focused on the future; our concentration makes AVIACOMP a leader and a developer of thermoplastic technology on new and high complexity applications. thermoplastics, composites, innovation, industry 4.0, material, and aerostructure Type: | 1 | 1 | 1 | 79 |
 | PHOT'Innov [Automatic translation follows] Innovation in Photonics PHOT’Innov offers the Distribution and Custom Development of INNOVATIVE high-tech optoelectronic equipment with high added value to serve the Photonics Industry, a key industry in New Aquitaine. photonics, imaging, spectrometry, and laser | 0 | 0 | 0 | 3 |
 | ADMIR Analysis With our active Digital Multispectral InfraRed, the bio-analysis gets faster. ADMIR is a deep tech start-up related to biomedical applications developing and manufacturing a diagnostic aid instrument with its mid-infrared spectroscopic imaging system and its machine learning software suite. The system provides infrared spectral fingerprints for each pixel of the sample image, revealing its biochemical content in less than 1 min. ADMIR instrument is a tool for massive analysis to accelerate and secure the diagnosis as well as a great research tool. It opens a new route toward tissue or cell analysis for cancer diagnosis or further biomedical applications offering … Type: | 3 | 3 | 0 | 10 |
 | ami - advanced magnetic interaction Unlock tomorrow's interactions #ihm #interaction #technology #metaverse #display #computerperipherals #tablets The leading pioneer in Augmented Interaction Technology ami's technology comes from years of research in magnetometry in the aerospace and defense fields and was born in the CEA LETI (French Energy & Alternative Energies Commission and its electronics laboratory) considered the world’s most innovative research institution, according to Reuters. After 4 years of incubation, the company was created in 2014. The company combines state-of-the-art expertise in embedded systems, algorithms & signal processing applied to magnetism, with a strong expertise in user experiences. In a world where digital technology is omnipresent, … | 4 | 2 | 2 | 21 |
 | FOLLOW PATIENT [Automatic translation follows] FOLLOW PATIENT - Publisher of chronic disease monitoring solutions FOLLOW PATIENT is a publisher of health monitoring software. The company develops and distributes digital solutions to support patients with chronic diseases in their care pathway. FOLLOW SURG is the first solution that has been deployed and distributed. It is a remote monitoring platform for patients with obesity, whether before and after their bariatric surgery, for monitoring the placement of a gastric balloon or for nutritional monitoring. More information on www.followsurg.com FOLLOW METRIOS is the second monitoring book that has been developed for people with endometriosis. More information … Type: | 1 | 1 | 1 | 5 |
 | LABORATOIRES AXAMED SA [Automatic translation follows] HealthCare Innovation Partner Based in Paris, Laboratoires AXAMED®, have a strong capacity for innovation, specializing in the design, development, and marketing of innovative health products in the vast field of family health, electronic self-diagnosis for medical use, prevention and treatment of pain, family hygiene, well-being, and innovative food supplements sold under the NovaBoost® brand. The innovative medical products and devices designed by Laboratoires AXAMED® integrate technology and design and are focused on needs and uses. Laboratoires AXAMED® products provide comfort of use and well-being for patients/users. health, medical devices, prevention and treatment of pain, pharmaceutical, electronic self-diagnosis, … Type: | 0 | 0 | 0 | 15 |
 | Sim&Cure Shaping the future of endovascular treatments. For more information about our products, visit our website! Founded in 2014 and located in the vibrant Medtech ecosystem in Montpellier, France, Sim&Cure is a digital start-up focused on Improving patient outcome and physician experience of endovascular treatment by combining Digital Twin and AI Technologies. As new technologies progress through the medical network, S&C will help its partners to flatten the learning curve. Sim&Cure's philosophy focuses on driving innovation in the healthcare industry and helping to improve treatments strategies in order to secure patient care. Sim&Cure has won the prestigious i-Lab national contest twice … Type: | 4 | 3 | 2 | 70 |
 | Enterome Delivering the promise of immunotherapy Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological insights from the millions of gut bacterial proteins in constant cross-talk with the human body. The company is currently developing a pipeline of drug candidates consisting of OncoMimicsTM peptide-based immunotherapies for the treatment of cancer. EO2463 is in a Phase 2 clinical trial for indolent non-Hodgkin lymphoma, demonstrating a benign … Tags: FrenchTech2030 Type: | 10 | 4 | 5 | 80 |
 | Stendo® [Automatic translation follows] Committed to #good #health and #well-being Unique technique and technologies. #Pulsotherapy #tissuemobilization #liquidfluxactivation #madeinfrance www.stendo.fr Type: | 3 | 2 | 0 | 14 |
 | BONE 3D Personalized medicine for practitioners and hospitals BONE 3D is the French medtech specialized in 3D printing for the medical field From identification of the requirements to production, all our innovative products - anatomical models, surgical simulators and medical devices - are codeveloped with doctor-engineers and surgeons, to optimize their relevance and enhance the physician and patient experience. In 2020, BONE 3D launched its HospiFactory offer to make its expertise available to healthcare establishments through on-site 3D printer farms and access to a dedicated design office. CAD-CAM, Additive printing, Vétérinaire, Innovation, Conception, Sur-mesure, Surgical Simulation, Medical training, and Medical 3D printing Type: | 11 | 2 | 10 | 10 |
 | ErVimmune Targeting shared unconventional tumor antigens in cancer immunotherapy R&D oncology | 5 | 2 | 4 | 17 |
 | TECMOLED [Automatic translation follows] TECMOLED is a start-up that has created a connected sensor dedicated to risk prevention and safety at work. TECMOLED, an innovative start-up, develops and markets the first monitoring and AI system to improve the care of Tri2 and Tri3 patients in hospital and military emergencies. oximetry, blood pressure, embedded systems, medical solutions, and Artificial Intelligence Type: | 24 | 7 | 0 | 2 |
 | GUICHA GUICHA is a retail company based out of 130 AVENUE MICHEL BAROIN, ST JULIEN LES VILLAS, France. | 1 | 1 | 1 | 1 |
 | BIORIZON BIORIZON is a real estate company based out of 23 RUE DE MOEUVRES, INCHY EN ARTOIS, France. Type: | 5 | 1 | 4 | N/A |
 | SeaBeLife Biotech Solutions to deprogram cell death : A breakthrough innovation to treat and prevent severe pathologies We develop small molecules that inhibit regulated necrosis using an original mechanism of action. Regulated necrosis is one of the recently identified pathophysiological factors in many diseases with severe outcomes. The technical, therapeutic and economic potential is major. Our activity focuses on the development of drugs inhibiting regulated necrosis, from the selection of the molecule to the proof of efficacy in the patient. We focus on acute and orphan diseases because preclinical and clinical development is facilitated, allowing proof of concept (POC) to be provided … Type: | 15 | 4 | 12 | 15 |
 | Perha Pharmaceuticals From Sea to Pharmacy Perha Pharmaceuticals is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors and developing them up to proof-of-concept in man. Perha Pharma focuses its research on two main diseases: cognitive disorders associated with Down syndrome (DS) and Alzheimer’s disease (AD), and hearing loss (HL) induced by ototoxic products. The first proof-of-concept in man should be achieved in both pathologies through niche indications: cognitive deficits in DS and hearing loss induced by cis-platin or aminoglycoside antibiotics. Perha Pharma was co-founded in April 2019 by Dr Laurent MEIJER, Chairman & CSO, former distinguished Director … Type: | 5 | 5 | 0 | 12 |
 | EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: | 9 | 1 | 8 | 4 |
 | ComThings One RF tool to (almost) rule them all ComThings is a French startup, located in Nice in the French Riviera, focused on the PandwaRF RF analysis tool and RF penetration testing tools for professionals and law enforcement agencies. The ComThings team has been assembled in July 2013 by 2 skilled and experienced engineers, with a strong background in software and telecommunications. The company has been officially created in April 2014. This creation is the result of 2 years of research, used to develop a proof of concept and validate the innovative technology behind our solution. Wireless communication, RF transceivers, Penetration … | 2 | 1 | 0 | 7 |
 | AURA-AERO "Change the Frame" AURA AERO was born in Toulouse, a city shaped by its aeronautical heritage. This passionate team is led by its three co-founders: Jérémy Caussade, Fabien Raison and Wilfried Dufaud. Right from the start, AURA AERO can leverage the deep expertise of a multi-disciplinary team composed of established professionals. In a world in perpetual evolution, AURA AERO's growth must demonstrate both excellence and efficiency: Applying the latest technologies, such as digital tools, using carefully selected solutions and taking a global approach to the markets... This is what will give it the edge in a global, competitive environment. AURA … Type: | 30 | 15 | 25 | 236 |
 | Futura Gaïa [Automatic translation follows] Futura Gaïa designs turnkey vertical farms that are environmentally friendly and easy to operate Futura Gaïa offers plant sourcing security solutions for the food, cosmetic, pharmaceutical and nutraceutical sectors, ranging from supply contracts to the delivery of turnkey vertical farms that are environmentally friendly and easy to operate Type: | 35 | 14 | 27 | 23 |
 | Kapsera Unlocking a sustainable future 🎯Our mission Kapsera offers natural and innovative formulations for microbials based biofertilizers and biopesticides. 🚀Our ambition We bridge the gap between sustainability and productivity in agriculture by upgrading biofertilizers and biopesticides with cutting-edge formulation technologies. Agriculture, Biotechnology, Microfluidic, Microbiology, Formulation, Encapsulation, Biostimulants, Biopesticides, and Microbials Type: | 16 | 6 | 11 | 19 |
 | NOBRAK NOBRAK, one thread ahead ! NOBRAK is a tech-based company which develops innovative technologies for technical textiles and composite materials. NOBRAK is using these technologies to design, produce and distribute personalized objects. On the other hand, NOBRAK proposes its technologies to third party companies to produce textiles and/or composite parts. NOBRAK is doing its best to limit the environmental footprint of its products/activities by using natural fibers and bio-based/renewable/recycled materials when possible but also by using energy-efficient technologies. Composite materials, Thermoplastic, Technical textiles, Smart textiles, Natural fibers, Innovation, Complex shape parts, and Multi-functional materials Type: | 6 | 1 | 4 | 11 |
 | Japet Medical Medical technology for health at work. Japet Medical is a exoskeleton manufacturer and integrator. This European startup combines medical technologies, textile expertise and modern robotics to create devices that relieve everyday aches and pains. Its Japet.W+ exoskeleton is the only motorized exoskeleton that protects employees' backs in all their movements. Every day, Japet Medical's teams help companies successfully integrate exoskeletons to combat musculoskeletal disorders. Find us on : https://www.japet.eu/ Robotics, Healthcare, Exoskeleton, Rehabilitation, health at work, Wearable Medicine, exosquelette, TMS, prévention, robotique, SST, QVCT, and RQTH Type: | 26 | 10 | 16 | 40 |
 | SPYGEN Putting innovation at the service of knowledge and protection of life. Created in 2011, SPYGEN is a "Mission lead company" that aims to improve the monitoring and conservation of aquatic and terrestrial biodiversity worldwide, through the study of environmental DNA (eDNA). SPYGEN has been certified B Corp since 2018, and has been a member of the french "Community of Companies with a Mission" since 2020. The company's headquarters are located in Le Bourget du Lac (Savoie - France). ADN environnemental, Biotechnologies, Environnement, Biodiversité, Génétique, and Conservation | 16 | 3 | 11 | 15 |
 | Entoma Petfood 100% natural petfood made with sustainable & eco-friendly insect proteins! 🐶🐱💚🦋 At Entoma Petfood we only wish the best for our dogs and our planet! We therefore develop delicious natural treats and complete food for your dog based on innovative protein sources: Insects (Hermetia illucens). Focusing on quality and sustainability, our natural products are both beneficial for your dog and for the planet ! petfood, natural petfood, dog food, snacks, treats, and dry petfood Type: | 3 | 0 | 3 | 1 |
 | REGEnLIFE Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, … Type: | 16 | 3 | 12 | 11 |
 | MT-act FROM DISCOVERY TO THERAPEUTICS MT-act is a CNRS spin-off. #techtransfer We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them. We developed a technology platform to charter an entirely neglected pharmaceutical space. MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired. Drug development, Microtubules, Tubulin code, Preclinical, Drug screening, first-in-class, and drug discovery Type: | 2 | 1 | 1 | 7 |
 | Quantum Surgical Standardize minimally invasive cancer treatment Quantum Surgical is a French company founded in Montpellier, France, speacialized in medical robotics and AI. Its Epione® robotic percutaneous ablation platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. Hundreds of patients have already been treated worldwide. Co-founded in 2017 and with a team of 110+ employees, Quantum Surgical is based in Montpellier, with offices in Miami, Florida. Quantum Surgical received the Prix Galien USA … Tags: FrenchTech2030 Type: | 38 | 10 | 33 | 119 |
 | Panaxium The BCI to Heal the Human Brain. Toronto, Canada and Aix-en-Provence, France. Together with world-renowned surgeons, neurologists, and neuroscientists, Panaxium is developing an iontronic precision neuro-stimulation BCI therapy to help restore normalcy for the 100 Million people worldwide who have survived a brain injury and are living with devastating cognitive, motor, and speech impairments. | 3 | 2 | 2 | 21 |
 | Odimma Therapeutics Empowering Personalized Immunotherapy to Treat Cancer Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has … Type: | 10 | 3 | 8 | 7 |
 | IA Medical [Automatic translation follows] Today, let's write the health pathways of tomorrow! IA Medical is a French start-up that uses generative artificial intelligence to serve mental health through a unique platform in Europe, unique because we are the first to make our chatbots boosted by the large language model like GPT available to the general public. If you are between 40 and 60 years old, you are part of the sandwich generation, caught between professional demands and helping your aging parents and children. A complex situation, exacerbated by discouraging administrative procedures. For 4 years, IA Medical has been providing everyone with … Type: | 21 | 2 | 9 | 7 |
 | SYNEIKA Treatment of chronic pathologies by non-invasive neurostimulation Manufacturer of neuronavigators for TMS, Syneika offers therapeutic solutions to alleviate chronic neurological and psychiatric diseases using a non-invasive neurostimulation technique: neuronavigated Transcranial Magnetic Stimulation (TMS). Syneika One, the neuronavigator designed by Syneika, was developed in collaboration with doctors and nurses. It is a fully integrated neuronavigator offering precision and ease of use in daily work. Syneika One neuronavigation for TMS aims to make repetitive Transcranial Magnetic Stimulation therapy accessible to any care team. It has been designed to fit the time constraints of an intensive therapeutic activity. To this end, powerful algorithms … Type: | 2 | 0 | 2 | 5 |
 | CTIBiotech Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … Type: | 18 | 2 | 14 | 21 |
 | Kickmaker Design & industrialization global firm for high-tech projects, from prototype to mass- production. Created in 2016, KICKMAKER is a community of talents with multidisciplinary and complementary profiles, driven by the same passion for high-tech product development and industrialization challenges. Present in France, China and the United States, our community counts more than 200 passionate kickers. We are proud to support our partners, large corporations, SMEs and startups from the prototyping phase to mass production. KICKMAKER is active in robotics, medical, mobility, consumer electronics and connected objects with a real maker culture. Eco-Design, embedded IA, industry 5.0, the fight against programmed … Type: | 113 | 14 | 109 | 262 |
 | AIXIAL GROUP Bringing reliability and expertise to clinical development Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing Biometrics and Clinical Research, … Type: | 1 | 1 | 0 | 744 |
 | NBread-Process Transformer Mieux et Différemment, pour le Meilleur des Aliments ! NBread-Process is an breakthrough innovative technology and a pioneering product, protected by a patent and carried by a patent and carried by a team that imagines and develops solid food foams from any raw material. Type: | 1 | 1 | 0 | 4 |
 | Dioxycle Industrial solutions to carbon dioxide emissions Dioxycle is pioneering breakthrough carbon utilization technologies that convert industrial emissions into sustainable chemicals with unprecedented energy and cost efficiency. By displacing fossil fuels for the production of key chemicals, Dioxycle has the potential to ultimately reduce over 800 million tons of CO2 per year, representing over 1% of the world's emissions. At Dioxycle, we believe that profitability is essential to trigger adoption of decarbonization technologies at the scale and speed required to reach our net-zero goals. With this in mind, our team is innovating across chemical, mechanical and system engineering to turn carbon … Type: | 24 | 13 | 12 | 24 |
Startup